Central Studies


HomeSponsors/CROsInitial SubmissionCentral Studies


When Quorum Review IRB is identified as the central IRB for a study, the sponsor must submit the following documents to Quorum Review IRB on behalf of investigators:

  • Study protocol
  • All proposed consent forms (in electronic Microsoft Word format)
  • Investigator’s brochures, package inserts, or device background literature for all primary and comparator drugs/devices
  • Central Study Questionnaire
  • Proposed study-wide advertisements and recruitment materials
  • Proposed study-wide participant study materials (diaries, questionnaires, written study instructions, etc.)
  • Device Study Submission form (as applicable)

The following items must be submitted by the investigator (under the central model these can/should be submitted separate from the protocol information listed above):

  • Site Information Questionnaire
  • Principal investigator's current Curriculum Vitae – A CV template and sample are available. (Effective January 2008, the PI needs to submit a CV only once. We do not need additional copies of the CV for subsequent site submissions.)

Additional Requirements for Canadian Sites only:

  • Copy of current Medical License
  • Clinical Trial Budget

Depending on the site and study, some supplemental material may be necessary as part of the site submission, such as:

  • Letters of explanation (as required by the Site Information Questionnaire)
  • Compensation schedule attachment (Please see Compensation Template if sponsor has not provided one)
  • Conflict of Interest Statement
  • Documentation of any audits from regulatory agencies (FDA, Canada Ministry of Health, etc.) within the past three years
  • Institutional Jurisdiction Waiver Form (or an Institutional Authorization Agreement)
  • State law documentation
  • Advertising and recruitment materials
  • Written sponsor approval for advertising and recruitment materials
  • Written sponsor approval for unique consent form
  • Rationale for requested changes for unique consent form
  • Additional Site Information Questionnaire

Required

F-013 - Central Study Questionnaire
When a Sponsor or CRO chooses Quorum as the Central IRB for the study, this form should be completed and submitted as part of the initial protocol submission.

As Indicated

F-015 - Federal Funding Addendum
This form, along with supporting documentation named within this form, is required to be completed and submitted along with the Central Study Questionnaire for any studies which are funded in whole or in part by the federal government of the United States.

F-019 - Device Study Submission Form
Device studies require completion of a Quorum Review Device Study Submission Form at the time of initial study submission to Quorum.

F-020 - Exemption Determination Request
If an applicant would like Quorum Review to make a determination regarding whether research is exempt from review, this form should be submitted. The protocol must also accompany the Exemption Determination Request Form.

F-042 - Waiver of Documentation of Informed Consent Submission Form
This form is required if a Waiver of Documentation of Informed Consent will be necessary.

F-043 - Waiver or Alteration of Informed Consent Submission Form
This form is required if a Waiver or Alteration of Informed Consent will be necessary.

Guidance

F-025 - Board Meeting Schedule
This schedule provides a complete listing Quorum's meeting dates and submission deadlines for the entire year.

G-034 - Consent Form Development Guide
This guide briefly describes Quorum Review's consent form editing process.

G-035 - Consenting Research Participant Guidelines
This document contains some guidelines on consenting research participants, including sections on the informed consent process, the Principal Investigator's signature, Non-English speaking research participants, Illiterate participants, enrollment of minors, revised consent forms, and compliance with HIPAA privacy protections.

G-039 - Consent Form Versioning Guidelines
This guidance document helps customers understand Quorum Review's version management system for consent forms. Quorum issues consent form versions which are whole numbers, pointed or alpha-numeric.

G-041 - Submission Illustration for Central Studies
Illustration that provides a depiction of the initial submission process for Central Studies.

G-043 - Handbook for Quorum Review IRB (Requires an OnQ Portal Account)
The Handbook provides a guide for using Quorum Review IRB as an ethics review board. It contains policies, procedures, and guidelines to be used in preparing materials for Board review, as well as information on managing ongoing research activities, continuing and periodic review, and closing.

G-091 - Central Study Submission Checklist
This guidance document provides a comprehensive listing of the materials that a sponsor/CRO needs to provide to Quorum in an initial study submission.

Q.  What is the schedule of Board meetings and what are the submission deadlines?>>
Quorum Review IRB has three Boards and conducts up to eight convened Board meetings a week. New U.S. protocols can be submitted to three of these meetings (to Board I (Tuesday and Friday) or Board II (Wednesday)). To be scheduled to a meeting for review, a submission must be received (with all required elements) by 5:00 p.m. Pacific Time one (1) week prior to the meeting. U.S. amendments can be submitted to one of the daily meetings (Board III) and must be submitted by 5:00 p.m. PT 36 hours prior. Canadian research must be submitted (with all required elements) to the Wednesday meeting (Board II) by 5:00 p.m. PT the prior Wednesday.
Q.    Where can I find the Board Roster?>>
Quorum posts the Board Roster on our web portal. You can find this by logging on to the web portal and selecting “IRB Roster.” Quorum also posts archived Board Rosters in this location if you need to locate a past Board Roster for your records.
Q.    Who is my Study Manager and what is their job?>>
Your Study Manager will be your key point of contact for protocol-related issues. The Study Manager will attend Board meetings where your study will be discussed and will communicate determinations back to you.
Q.    What happens after my study is assigned a Board Review date?>>
Once a complete set of submission elements is submitted for review, Quorum will assign a Study Manager to your study and schedule a review date. Following the Board review, your Study Manager will contact you with the outcome, including any consent form revisions or further information that the Board has requested.
Q.    What happens if the Board makes changes to my protocol or consent form?>>
If the Board has requested consent form revisions, you will be asked to review them and submit additional changes as appropriate. Once the consent forms are finalized and any follow-up issues are resolved, your Study Manager will provide you with a Letter of Approval.
Q.    Can you meet my tight deadline/ how can I make sure you meet that tight deadline for study startup?>>
Quorum works with sponsors to make sure that studies are started as quickly as possible. However, Quorum cannot issue final approval documents to the sites until they have been approved and the consent form has been finalized. If the timeline is tight it is especially important to respond to your Study Manager with any feedback on the consent form as quickly as possible so that the consent form may be finalized in a timely manner. Once the protocol has been reviewed sites may be scheduled for review while the Board and sponsor negotiate the consent form language. This helps minimize delays. Another item to note, complete site submissions must be received one week prior to a Board meeting to ensure review at or before that meeting; therefore, it would be best that your target site(s) submit as soon as possible.
Q.    What happens if the Board makes changes to my protocol or consent form?>>
If the Board has requested consent form revisions, you will be asked to review them and submit additional changes as appropriate. Once the consent forms are finalized and any follow-up issues are resolved, your Study Manager will provide you with a Letter of Approval.
Q.    How does the OnQ Portal work?>>
The Quorum Review IRB OnQ Portal is password-protected and available to study contacts at the site and sponsor level. Please contact Quorum Review IRB to learn more about this service or to request a portal account. Users can view, download, and print all Quorum Review IRB approval documents and most other Board correspondence. The OnQ Portal also offers a status report for tracking site submissions from initial review through the Board’s final decision. Users can submit materials for review electronically and securely through the OnQ Portal provided that the submission is not larger than 30 MB. For items that are larger than 30 MB either use a compression utility such as WinZip or e-mail items that are less than 50 MB to InitialStudySupport@QuorumReview.com. Alternatively you can mail or fax to the attention of Initial Study Support.
Q.    How do I get people signed on and removed from the portal?>>
The primary contact for a study, as designated on the Central Study Questionnaire, is automatically granted portal access for the study. If the primary contact would like to request to have additional users added or removed there are many ways to accomplish this. Prior to submitting your study the last page of the CSQ allows you to list additional users. Additionally, the primary contact can request additional users via email to their Study Manager or Quorum’s Initial Study Support team. It is also possible to request additional users through the Quorum web portal.
Q.    Who should I submit documents to (amendments, safety information, etc.)?>>
All documents for a study may be submitted via the OnQ Portal. Or, after your initial study submission any protocol-level information may be submitted to your assigned Study Manager via email. Quorum accepts this information via mail as well.
Q.    Is there a way for me to check on the status of the sites that have submitted for the study?>>
Yes. Log in to Quorum’s OnQ Portal, and click on “Reports.” Then, you can generate a site submission status report for any of the Protocols to which you have access. You will be able to see the status of the site (approved, in progress, not yet active) and whether any information is still needed for the site’s submission to be complete.
Q.    Why do I have to track changes I want into the consent form (for negotiations)/how do I do this?>>
Quorum asks that you track any requested changes into the clean, current version of the consent form and that you submit these changes along with the rationale for the changes. This allows the Board to see what changes have been requested to the current approved version of the consent form. Please turn on the “track changes” feature in Microsoft Word, and submit the consent form revisions electronically.
Q.    I don’t understand the changes the Board made to the consent or why they made them.>>
Please start by referencing Quorum’s Guide to Consent Form Development. In the tracked version of the consent form(s), you will see a superscript number (a small number slightly above the rest of the line) after each change or group of changes that correlates to a rationale for change in the document (attached). The superscript numbers do not appear in the “clean” version of the consent form(s). If you have any additional questions regarding the changes that were requested, please contact your Study Manager for more information.
Q.    I would like to submit my submission through the web portal but do not have an account?>>
Please contact Quorum Review IRB’s Initial Study Support team; they will provide you with your own account.
Q.    I am interested in transferring jurisdiction of a study from another IRB to Quorum, what should I do?>>
Quorum has created an efficient process for transferring jurisdiction of IRB oversight. Please contact Initial Study Support at (877) 472-9883 or InitialStudySupport@quorumreview.com if you’d like more information about this process.